Sign In
Buy NNOX
$1.51
-0.110 (-6.79%)
At Close: Jun 23, 2026
Insiders spill: The next big tech stock set to explode in value
10:06am, Tuesday, 20'th Feb 2024
2023 proved to be a rather fruitful year for tech investors, with NASDAQ finishing 43% up compared to the disappointment that was 2022.
13F Season: 3 Whales to Follow
06:21pm, Thursday, 15'th Feb 2024
Tracking 13F filings is crucial for market participants seeking to understand trends, identify potential investment opportunities, and monitor the transactions of Wall Street's most influential invest
Nvidia discloses investments in smaller AI firms
05:22pm, Thursday, 15'th Feb 2024
Nvidia (NVDA) has disclosed investments made in several emerging AI companies, sparking rallies across these stocks. Among the names benefiting include Soundhound (SOUN), Arm (ARM), and Nanox (NNOX).
Shares of Smaller AI Firms Rise After Nvidia Discloses Investments
03:19pm, Thursday, 15'th Feb 2024
Shares of smaller artificial intelligence (AI) firms reportedly experienced a rally Thursday (Feb. 15) after Nvidia, the world's leading AI chipmaker, disclosed its stake in them as of Dec. 31. This
Small AI Companies Soar After Chip Giant Reveals Stake
02:21pm, Thursday, 15'th Feb 2024
Through its SEC disclosure, Nvidia provided investors with more evidence of its long-term growth plan.
Nano-X Imaging (NNOX) Stock Soars 50% on Nvidia Investment
11:37am, Thursday, 15'th Feb 2024
Nvidia (NASDAQ: NVDA ) can add boosting a struggling company to its list of recent accomplishments. The Silicon Valley giant recently disclosed investments in several of its tech sector peers, includi
Nvidia Discloses Stakes In Arm, SoundHound AI, Nano-X And More
08:00pm, Wednesday, 14'th Feb 2024
Nvidia disclosed investments in Arm Holdings, SoundHound AI and more in its first-ever 13F SEC filing late Wednesday. ARM rose while SOUN stock soared.
Nano-X Imaging Ltd (NNOX) Q3 2023 Earnings Call Transcript
12:29pm, Tuesday, 28'th Nov 2023
Nano-X Imaging Ltd (NASDAQ:NNOX ) Q3 2023 Earnings Conference Call November 28, 2023 8:30 AM ET Company Participants Erez Meltzer - CEO Ran Daniel - CFO Mike Cavanaugh - IR Conference Call Participant
Israeli's Nano-X settles US SEC charges over costs of flagship imaging device
06:15pm, Friday, 29'th Sep 2023
Nano-X Imaging and its founder Ran Poliakine agreed to pay nearly $1.1 million to settle U.S. Securities and Exchange Commission charges accusing the Israeli medical imaging company of negligently mis
Nanox to Present at the Cantor Fitzgerald Global Healthcare Conference 2023 in September
08:30am, Wednesday, 13'th Sep 2023
NEVE ILAN, Israel, Sept. 13, 2023 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced its part
Nanox to Report Second Quarter 2023 Financial Results on August 17, 2023
04:05pm, Wednesday, 02'nd Aug 2023
NEVE ILAN, Israel, Aug. 02, 2023 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company," Nasdaq: NNOX) will report its financial results for the second quarter ended June 30, 2023 before m
Got $2,500? Buying Shares of This Medical Device Stock Right Now Could Be a Smart Move
07:27am, Sunday, 30'th Jul 2023
Nano-X is working to multiply the value of its top line in 2024. Its stock price will likely follow its sales upward at least part of the way.
Could Nano-X Imaging Stock Help You Become a Millionaire?
06:40am, Friday, 21'st Jul 2023
The Food and Drug Administration recently granted marketing clearance for the company's X-ray system. Nano-X believes it can make medical imaging more affordable and accessible.
Where Will Nano-X Imaging Be in 3 Years?
05:35am, Friday, 21'st Jul 2023
Nano-X now has approval from regulators in the U.S. to market its unique X-ray device. It'll be placing its systems mostly in places where there are few X-ray devices.
Nano-X Imaging - Some Good, Some Bad
03:01pm, Tuesday, 18'th Jul 2023
Israeli medical tech firm Nano-X Imaging is the top-rated healthcare equipment stock as per Seeking Alpha's Quant Rating. We explore what's behind the hype and lay down a few concerns. We conclude wit
